Reply to the Letter Regarding NADPH Oxidase Inhibitor
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Wind S, Beuerlein K, Eucker T, Muller H, Scheurer P, Armitage M
. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol. 2010; 161(4):885-98.
PMC: 2970907.
DOI: 10.1111/j.1476-5381.2010.00920.x.
View
2.
Clemmer J, Xiang L, Lu S, Mittwede P, Hester R
. Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability. Microcirculation. 2016; 23(3):221-9.
PMC: 4818684.
DOI: 10.1111/micc.12267.
View
3.
El-Bassossy H, Neamatallah T, Balamash K, Abushareb A, Watson M
. Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products. Biochem Biophys Res Commun. 2018; 499(4):992-997.
DOI: 10.1016/j.bbrc.2018.04.036.
View
4.
Kito K, Tanabe K, Sakata K, Fukuoka N, Nagase K, Iida M
. Endothelium-dependent vasodilation in the cerebral arterioles of rats deteriorates during acute hyperglycemia and then is restored by reducing the glucose level. J Anesth. 2018; 32(4):531-538.
DOI: 10.1007/s00540-018-2507-7.
View